Form 8-K - Current report:
SEC Accession No. 0001641172-25-007954
Filing Date
2025-05-01
Accepted
2025-04-30 20:23:59
Documents
13
Period of Report
2025-04-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 39422
  Complete submission text file 0001641172-25-007954.txt   212785

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE aim-20250430.xsd EX-101.SCH 3015
3 XBRL LABEL FILE aim-20250430_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE aim-20250430_pre.xml EX-101.PRE 24166
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3575
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 25898794
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)